Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$5.02 USD
+0.14 (2.87%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.01 -0.01 (-0.20%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/2/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | 0.31 |
Last EPS Surprise | -16.22% |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.51 |
Next Year | 0.53 |
EPS (TTM) | 0.67 |
P/E (F1) | 9.63 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 41.53M | 56.37M | 220.22M | 239.33M |
# of Estimates | 2 | 2 | 2 | 3 |
High Estimate | 41.60M | 56.60M | 220.23M | 244.00M |
Low Estimate | 41.46M | 56.14M | 220.20M | 235.10M |
Year ago Sales | 52.80M | 54.60M | 235.70M | 220.22M |
Year over Year Growth Est. | -21.34% | 3.24% | -6.57% | 8.68% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | 0.20 | 0.51 | 0.53 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.16 | 0.19 | 0.50 | 0.53 |
High Estimate | -0.16 | 0.20 | 0.52 | 0.70 |
Low Estimate | -0.16 | 0.19 | 0.50 | 0.35 |
Year ago EPS | 0.09 | 0.10 | 0.67 | 0.51 |
Year over Year Growth Est. | -277.78% | 100.00% | -23.88% | 3.92% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | 0.20 | 0.51 | 0.53 |
7 Days Ago | -0.16 | 0.20 | 0.51 | 0.53 |
30 Days Ago | -0.16 | 0.20 | 0.51 | 0.54 |
60 Days Ago | 0.11 | 0.11 | 0.71 | 0.81 |
90 Days Ago | 0.11 | 0.11 | 0.69 | 0.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | 0.20 | 0.51 | 0.53 |
Zacks Consensus Estimate | -0.16 | 0.20 | 0.51 | 0.53 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.63% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.31 | 0.17 | 0.10 | 0.09 | NA |
Estimate | 0.37 | 0.15 | 0.07 | -0.02 | NA |
Difference | -0.06 | 0.02 | 0.03 | 0.11 | 0.03 |
Surprise | -16.22% | 13.33% | 42.86% | 550.00% | 147.49% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more